Journal of Neurology Neurosurgery & Psychiatry · 2007 · 72 citations · 20 references
MedicineNeurologyPharmacotherapyEpilepsyNeuroimmunologyNeuropharmacologyAntiepileptic PharmacologyAntiepileptic PharmacotherapyAutoimmune EpilepsyAutoimmune Neurological DisordersDrug-resistant EpilepsySeizure ManagementAnti-glutamic Acid Decarboxylase AntibodiesAutoimmune Cerebellar AtaxiaGlutamic Acid Decarboxylase AntibodiesImmunosuppressive CompoundsRefractory Focal EpilepsySeizuresStiff-person SyndromeUpbeat Nystagmus
Anti-glutamic acid decarboxylase (GAD) antibodies are described in stiff-person syndrome and also in other neurological syndromes, including cerebellar ataxia and epilepsy. This paper reports the case of a patient who had chronic focal epilepsy, upbeat nystagmus and cerebellar ataxia, associated with a polyautoimmune response including anti-GAD antibodies. Both gait and nystagmus improved markedly after immunosuppressive treatment with corticosteroids and azathioprine. After the introduction of benzodiazepines, previously refractory seizures were completely controlled. Anti-GAD antibodies should be actively sought out in pharmacoresistant epilepsy, particularly if other neurological abnormalities are present. Combined treatment with immunosuppressants and gammahydroxybutyric acidergic agents may be highly effective.
20
Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies
Jérôme Honnorat, Albert Saiz, Bruno Giometto et al. · Archives of Neurology · 2001 · 384 citations
Medicine, Endocrinology, Neurology +15
Roger A. Barker, T Révész, Matthew Thom et al. · Journal of Neurology Neurosurgery & Psychiatry · 1998 · 302 citations · Full text
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy
Jukka Peltola, Petri Kulmala, Jouko Isojärvi et al. · Neurology · 2000 · 297 citations
Medicine, Neurology, Neuroscience +16